Semiconductors
Compare Stocks
4 / 10Stock Comparison
TRT vs NVEC vs FORM vs MRAM
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
TRT vs NVEC vs FORM vs MRAM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $101M | $429M | $11.28B | $502M |
| Revenue (TTM) | $49M | $26M | $840M | $57M |
| Net Income (TTM) | $-109K | $15M | $68M | $284K |
| Gross Margin | 19.7% | 78.7% | 42.1% | 51.5% |
| Operating Margin | 0.5% | 60.5% | 12.7% | -12.8% |
| Forward P/E | — | 18.9x | 66.5x | 860.4x |
| Total Debt | $2M | $740K | $45M | $3M |
| Cash & Equiv. | $11M | $2M | $103M | $44M |
TRT vs NVEC vs FORM vs MRAM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Trio-Tech Internati… (TRT) | 100 | 408.5 | +308.5% |
| NVE Corporation (NVEC) | 100 | 146.4 | +46.4% |
| FormFactor, Inc. (FORM) | 100 | 574.8 | +474.8% |
| Everspin Technologi… (MRAM) | 100 | 365.2 | +265.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRT vs NVEC vs FORM vs MRAM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRT is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 0.52, current ratio 5.03x
- Beta 0.52 vs MRAM's 2.85
NVEC carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 1.58, yield 4.5%
- Lower volatility, beta 1.58, Low D/E 1.3%, current ratio 28.21x
- Lower P/E (18.9x vs 860.4x)
- 57.7% margin vs TRT's -0.2%
FORM is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 2.8%, EPS growth -22.5%, 3Y rev CAGR 1.6%
- 19.5% 10Y total return vs MRAM's 168.2%
- +387.8% vs NVEC's +52.6%
MRAM is the clearest fit if your priority is growth.
- 9.5% revenue growth vs TRT's -13.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.5% revenue growth vs TRT's -13.8% | |
| Value | Lower P/E (18.9x vs 860.4x) | |
| Quality / Margins | 57.7% margin vs TRT's -0.2% | |
| Stability / Safety | Beta 0.52 vs MRAM's 2.85 | |
| Dividends | 4.5% yield; 2-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +387.8% vs NVEC's +52.6% | |
| Efficiency (ROA) | 24.8% ROA vs TRT's -0.2%, ROIC 21.2% vs 0.8% |
TRT vs NVEC vs FORM vs MRAM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRT vs NVEC vs FORM vs MRAM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NVEC leads in 3 of 6 categories
FORM leads 1 • TRT leads 0 • MRAM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVEC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FORM is the larger business by revenue, generating $840M annually — 31.9x NVEC's $26M. NVEC is the more profitable business, keeping 57.7% of every revenue dollar as net income compared to TRT's -0.2%. On growth, TRT holds the edge at +81.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $26M | $840M | $57M |
| EBITDAEarnings before interest/tax | $3M | $16M | $152M | -$4M |
| Net IncomeAfter-tax profit | -$109,000 | $15M | $68M | $284,000 |
| Free Cash FlowCash after capex | $137,000 | $14M | -$5M | -$1M |
| Gross MarginGross profit ÷ Revenue | +19.7% | +78.7% | +42.1% | +51.5% |
| Operating MarginEBIT ÷ Revenue | +0.5% | +60.5% | +12.7% | -12.8% |
| Net MarginNet income ÷ Revenue | -0.2% | +57.7% | +8.1% | +0.5% |
| FCF MarginFCF ÷ Revenue | +0.3% | +54.9% | -0.6% | -2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +81.6% | +5.3% | +32.0% | +13.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -76.0% | +27.5% | +2.2% | +74.4% |
Valuation Metrics
Evenly matched — TRT and NVEC each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 28.2x trailing earnings, NVEC trades at a 87% valuation discount to FORM's 209.7x P/E. On an enterprise value basis, NVEC's 26.9x EV/EBITDA is more attractive than FORM's 100.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $101M | $429M | $11.3B | $502M |
| Enterprise ValueMkt cap + debt − cash | $92M | $428M | $11.2B | $461M |
| Trailing P/EPrice ÷ TTM EPS | -2416.67x | 28.21x | 209.68x | -827.31x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 18.93x | 66.48x | 860.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.28x | — | — |
| EV / EBITDAEnterprise value multiple | 30.78x | 26.86x | 100.94x | — |
| Price / SalesMarket cap ÷ Revenue | 2.78x | 16.27x | 14.37x | 9.09x |
| Price / BookPrice ÷ Book value/share | 2.98x | 7.36x | 10.94x | 7.04x |
| Price / FCFMarket cap ÷ FCF | — | 29.62x | 960.69x | 160.68x |
Profitability & Efficiency
NVEC leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NVEC delivers a 25.6% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $-0 for TRT. NVEC carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to TRT's 0.05x. On the Piotroski fundamental quality scale (0–9), NVEC scores 6/9 vs MRAM's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -0.3% | +25.6% | +6.7% | +0.4% |
| ROA (TTM)Return on assets | -0.2% | +24.8% | +5.6% | +0.3% |
| ROICReturn on invested capital | +0.8% | +21.2% | +5.4% | -18.4% |
| ROCEReturn on capital employed | +0.7% | +26.0% | +6.1% | -9.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.05x | 0.01x | 0.04x | 0.05x |
| Net DebtTotal debt minus cash | -$9M | -$973,617 | -$58M | -$41M |
| Cash & Equiv.Liquid assets | $11M | $2M | $103M | $44M |
| Total DebtShort + long-term debt | $2M | $740,423 | $45M | $3M |
| Interest CoverageEBIT ÷ Interest expense | 0.57x | — | 252.69x | — |
Total Returns (Dividends Reinvested)
FORM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MRAM five years ago would be worth $41,207 today (with dividends reinvested), compared to $13,865 for NVEC. Over the past 12 months, FORM leads with a +387.8% total return vs NVEC's +52.6%. The 3-year compound annual growth rate (CAGR) favors FORM at 72.9% vs NVEC's 4.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.8% | +45.8% | +144.4% | +113.8% |
| 1-Year ReturnPast 12 months | +121.8% | +52.6% | +387.8% | +266.4% |
| 3-Year ReturnCumulative with dividends | +169.5% | +13.0% | +417.3% | +195.5% |
| 5-Year ReturnCumulative with dividends | +124.8% | +38.6% | +273.9% | +312.1% |
| 10-Year ReturnCumulative with dividends | +248.3% | +124.0% | +1952.2% | +168.2% |
| CAGR (3Y)Annualised 3-year return | +39.2% | +4.2% | +72.9% | +43.5% |
Risk & Volatility
Evenly matched — TRT and NVEC each lead in 1 of 2 comparable metrics.
Risk & Volatility
TRT is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than MRAM's 2.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVEC currently trades 98.4% from its 52-week high vs TRT's 60.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.52x | 1.58x | 2.02x | 2.85x |
| 52-Week HighHighest price in past year | $19.10 | $90.00 | $159.09 | $22.69 |
| 52-Week LowLowest price in past year | $4.42 | $57.21 | $26.08 | $5.49 |
| % of 52W HighCurrent price vs 52-week peak | +60.7% | +98.4% | +90.9% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 58.4 | 63.8 | 66.5 | 75.3 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 53K | 1.6M | 1.0M |
Analyst Outlook
NVEC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: FORM as "Hold", MRAM as "Buy". Consensus price targets imply -14.7% upside for FORM (target: $123) vs -58.2% for MRAM (target: $9). NVEC is the only dividend payer here at 4.51% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $123.38 | $9.00 |
| # AnalystsCovering analysts | — | — | 19 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | +4.5% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 2 | — | — |
| Dividend / ShareAnnual DPS | — | $4.00 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | 0.0% |
NVEC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FORM leads in 1 (Total Returns). 2 tied.
TRT vs NVEC vs FORM vs MRAM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRT or NVEC or FORM or MRAM a better buy right now?
For growth investors, Everspin Technologies, Inc.
(MRAM) is the stronger pick with 9. 5% revenue growth year-over-year, versus -13. 8% for Trio-Tech International (TRT). NVE Corporation (NVEC) offers the better valuation at 28. 2x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Everspin Technologies, Inc. (MRAM) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRT or NVEC or FORM or MRAM?
On trailing P/E, NVE Corporation (NVEC) is the cheapest at 28.
2x versus FormFactor, Inc. at 209. 7x. On forward P/E, NVE Corporation is actually cheaper at 18. 9x.
03Which is the better long-term investment — TRT or NVEC or FORM or MRAM?
Over the past 5 years, Everspin Technologies, Inc.
(MRAM) delivered a total return of +312. 1%, compared to +38. 6% for NVE Corporation (NVEC). Over 10 years, the gap is even starker: FORM returned +1952% versus NVEC's +124. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRT or NVEC or FORM or MRAM?
By beta (market sensitivity over 5 years), Trio-Tech International (TRT) is the lower-risk stock at 0.
52β versus Everspin Technologies, Inc. 's 2. 85β — meaning MRAM is approximately 446% more volatile than TRT relative to the S&P 500. On balance sheet safety, NVE Corporation (NVEC) carries a lower debt/equity ratio of 1% versus 5% for Trio-Tech International — giving it more financial flexibility in a downturn.
05Which is growing faster — TRT or NVEC or FORM or MRAM?
By revenue growth (latest reported year), Everspin Technologies, Inc.
(MRAM) is pulling ahead at 9. 5% versus -13. 8% for Trio-Tech International (TRT). On earnings-per-share growth, the picture is similar: NVE Corporation grew EPS 1. 0% year-over-year, compared to -173. 9% for Everspin Technologies, Inc.. Over a 3-year CAGR, FORM leads at 1. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRT or NVEC or FORM or MRAM?
NVE Corporation (NVEC) is the more profitable company, earning 57.
7% net margin versus -1. 1% for Everspin Technologies, Inc. — meaning it keeps 57. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVEC leads at 60. 5% versus -11. 8% for MRAM. At the gross margin level — before operating expenses — NVEC leads at 78. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRT or NVEC or FORM or MRAM more undervalued right now?
On forward earnings alone, NVE Corporation (NVEC) trades at 18.
9x forward P/E versus 860. 4x for Everspin Technologies, Inc. — 841. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FORM: -14. 7% to $123. 38.
08Which pays a better dividend — TRT or NVEC or FORM or MRAM?
In this comparison, NVEC (4.
5% yield) pays a dividend. TRT, FORM, MRAM do not pay a meaningful dividend and should not be held primarily for income.
09Is TRT or NVEC or FORM or MRAM better for a retirement portfolio?
For long-horizon retirement investors, Trio-Tech International (TRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), +248. 3% 10Y return). Everspin Technologies, Inc. (MRAM) carries a higher beta of 2. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TRT: +248. 3%, MRAM: +168. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRT and NVEC and FORM and MRAM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TRT is a small-cap quality compounder stock; NVEC is a small-cap income-oriented stock; FORM is a mid-cap quality compounder stock; MRAM is a small-cap quality compounder stock. NVEC pays a dividend while TRT, FORM, MRAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.